Embleema
PrivateLast Round
Series A
Feb 6, 2019
Total Funding Raised
$3.82M
Company Overview
Embleema operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in February 2019.
Embleema is a health technology company that provides a platform for registries and real-world studies, unifying genomic, clinical, and patient-reported data to generate regulatory-grade evidence for research organizations and life science sponsors.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Precision Medicine, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Embleema Comparables
Compare Embleema with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OM1 | 77% | |
| Verana Health | 76% | |
| Dassault Systèmes | 75% |
For institutional investors. Book with your work email.
Embleema Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 6, 2019 | ||||
| Accelerator | Feb 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Embleema Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator, Series A |
| Alchemist Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 121% MoM, reaching 801.
- Nov 9, 2025
Monthly visitors increased 54% MoM.
For institutional investors. Book with your work email.
Embleema Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Embleema's valuation, stock price, and market status.
Is Embleema a public or private company?
Embleema is a private company.
What is the current stock price of Embleema?
Embleema is a private company, so its shares have no public market price. Caplight tracks Embleema's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Embleema worth (valuation)?
Valuation information for Embleema is not publicly available.
Can I buy Embleema stock?
Embleema shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Embleema's last funding round?
Embleema's most recent funding round was Series A on February 6, 2019.
Who are the main investors in Embleema?
Key investors in Embleema include Techstars.
Will Embleema IPO soon?
No public IPO plans have been announced for Embleema.
How can I track Embleema secondary market activity?
Caplight tracks bids, offers, and trades in Embleema's shares on secondary markets.